Skip to main content
. 2020 Nov 30;33(Suppl 1):e161–e166. doi: 10.1097/MEG.0000000000001985

Fig. 2.

Fig. 2.

Comparison of the reduction in urine osmolality between tolvaptan responders and nonresponders. P-values <0.05 were considered statistically significant.